Vault-13

Avidity Partners Management LP

DALLAS, TX · CIK 1791827 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2020 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Dallas, TX (main office)United States United Statesabout 5
New York, NYUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$498.8m reported value +2.9% vs Q1 2025
55positions
49.1%in top 10
17 new 18 added 13 reduced 25 sold out vs Q1 2025

Options: 1 call positions ($3.2m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 1,499,942 $39.0m7.82% 7.82% AddedShares held: Q3 2024 1.7m, Q4 2024 1.1m, Q1 2025 980.9k, Q2 2025 1.5m +519.0k +519,000 52.9%
2 BOSTON SCIENTIFIC CORP COM BSX BSX 321,800 $34.6m6.93% 6.93% ReducedShares held: Q3 2024 962.0k, Q4 2024 515.0k, Q1 2025 336.0k, Q2 2025 321.8k -14.2k -14,200 -4.2%
3 NATERA INC COM NTRA NTRA 199,300 $33.7m6.75% 6.75% AddedShares held: Q3 2024 556.4k, Q4 2024 223.8k, Q1 2025 119.2k, Q2 2025 199.3k +80.1k +80,100 67.2%
4 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,742,902 $32.5m6.51% 6.51% AddedShares held: Q3 2024 2.9m, Q4 2024 2.9m, Q1 2025 1.7m, Q2 2025 1.7m +22.0k +22,000 1.3%
5 EXACT SCIENCES CORP COM EXAS EXAS 355,000 $18.9m3.78% 3.78% AddedShares held: Q3 2024 588.0k, Q4 2024 603.0k, Q1 2025 353.0k, Q2 2025 355.0k +2.0k +2,000 0.6%
6 TENET HEALTHCARE CORP COM NEW THC THC 106,000 $18.7m3.74% 3.74% AddedShares held: Q3 2024 253.0k, Q4 2024 137.0k, Q1 2025 72.0k, Q2 2025 106.0k +34.0k +34,000 47.2%
7 DEXCOM INC COM DXCM DXCM 210,500 $18.4m3.68% 3.68% AddedShares held: Q3 2024 240.0k, Q4 2024 318.0k, Q1 2025 180.0k, Q2 2025 210.5k +30.5k +30,500 16.9%
8 DANAHER CORPORATION COM DHR DHR 89,700 $17.7m3.55% 3.55% AddedShares held: Q3 2024 95.0k, Q4 2024 67.0k, Q1 2025 44.5k, Q2 2025 89.7k +45.2k +45,200 101.6%
9 HINGE HEALTH INC CL A HNGE HNGE 322,344 $16.7m3.34% 3.34% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 322.3k
10 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 27,100 $14.7m2.95% 2.95% NewShares held: Q3 2024 148.2k, Q4 2024 64.8k, Q1 2025 0, Q2 2025 27.1k
11 GENMAB A/S SPONSORED ADS GMAB GMAB 650,000 $13.4m2.69% 2.69% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 650.0k
12 REPLIGEN CORP COM RGEN RGEN 106,500 $13.2m2.66% 2.66% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 106.5k
13 THERMO FISHER SCIENTIFIC INC COM TMO TMO 29,600 $12.0m2.41% 2.41% AddedShares held: Q3 2024 68.6k, Q4 2024 44.6k, Q1 2025 15.5k, Q2 2025 29.6k +14.1k +14,100 91.0%
14 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 689,500 $11.6m2.32% 2.32% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 481.0k, Q2 2025 689.5k +208.5k +208,500 43.4%
15 JADE BIOSCIENCES INC COM NEW JBIO JBIO 1,127,186 $11.3m2.26% 2.26% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.1m
16 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,064,500 $10.2m2.05% 2.05% AddedShares held: Q3 2024 1.8m, Q4 2024 1.4m, Q1 2025 800.0k, Q2 2025 1.1m +264.5k +264,500 33.1%
17 UNITEDHEALTH GROUP INC COM UNH UNH 32,000 $10.0m2.00% 2.00% ReducedShares held: Q3 2024 87.4k, Q4 2024 60.0k, Q1 2025 50.5k, Q2 2025 32.0k -18.5k -18,500 -36.6%
18 MCKESSON CORP COM MCK MCK 13,500 $9.9m1.98% 1.98% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.5k
19 AXSOME THERAPEUTICS INC COM AXSM AXSM 94,500 $9.9m1.98% 1.98% AddedShares held: Q3 2024 296.1k, Q4 2024 188.0k, Q1 2025 77.0k, Q2 2025 94.5k +17.5k +17,500 22.7%
20 CENCORA INC COM COR COR 32,800 $9.8m1.97% 1.97% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 39.3k, Q2 2025 32.8k -6.5k -6,500 -16.5%
21 HEALTHEQUITY INC COM HQY HQY 92,000 $9.6m1.93% 1.93% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 78.0k, Q2 2025 92.0k +14.0k +14,000 17.9%
22 ENCOMPASS HEALTH CORP COM EHC EHC 74,000 $9.1m1.82% 1.82% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 74.0k
23 REVOLUTION MEDICINES INC COM RVMD RVMD 228,600 $8.4m1.69% 1.69% AddedShares held: Q3 2024 790.0k, Q4 2024 446.2k, Q1 2025 213.0k, Q2 2025 228.6k +15.6k +15,600 7.3%
24 AKERO THERAPEUTICS INC COM AKRO AKRO 134,000 $7.2m1.43% 1.43% AddedShares held: Q3 2024 0, Q4 2024 82.0k, Q1 2025 57.0k, Q2 2025 134.0k +77.0k +77,000 135.1%
25 OMADA HEALTH INC COM OMDA OMDA 390,600 $7.1m1.43% 1.43% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 390.6k
26 BEAM THERAPEUTICS INC COM BEAM BEAM 409,400 $7.0m1.40% 1.40% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 709.5k, Q2 2025 409.4k -300.1k -300,117 -42.3%
27 HUMANA INC COM HUM HUM 27,600 $6.7m1.35% 1.35% ReducedShares held: Q3 2024 129.7k, Q4 2024 89.2k, Q1 2025 81.0k, Q2 2025 27.6k -53.4k -53,400 -65.9%
28 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 1,858,596 $6.4m1.28% 1.28% ReducedShares held: Q3 2024 3.4m, Q4 2024 2.7m, Q1 2025 2.2m, Q2 2025 1.9m -338.7k -338,674 -15.4%
29 ORGANON & CO COMMON STOCK OGN OGN 640,000 $6.2m1.24% 1.24% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 535.0k, Q2 2025 640.0k +105.0k +105,000 19.6%
30 BRIDGEBIO PHARMA INC COM BBIO BBIO 140,000 $6.0m1.21% 1.21% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 75.0k, Q2 2025 140.0k +65.0k +65,000 86.7%
31 INSMED INC COM PAR $.01 INSM INSM 59,000 $5.9m1.19% 1.19% ReducedShares held: Q3 2024 592.0k, Q4 2024 232.8k, Q1 2025 107.0k, Q2 2025 59.0k -48.0k -48,000 -44.9%
32 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 19,000 $5.8m1.15% 1.15% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 19.0k
33 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 154,000 $5.6m1.12% 1.12% ReducedShares held: Q3 2024 752.0k, Q4 2024 352.0k, Q1 2025 322.1k, Q2 2025 154.0k -168.1k -168,100 -52.2%
34 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,477,255 $4.9m0.98% 0.98% AddedShares held: Q3 2024 7.4m, Q4 2024 7.5m, Q1 2025 7.5m, Q2 2025 7.5m +55 +55 0.0%
35 ORUKA THERAPEUTICS INC COM ORKA ORKA 352,124 $3.9m0.79% 0.79% UnchangedShares held: Q3 2024 790.9k, Q4 2024 352.1k, Q1 2025 352.1k, Q2 2025 352.1k
36 IMMUNIC INC COM COM 5,615,811 $3.9m0.79% 0.79% AddedShares held: Q3 2024 8.3m, Q4 2024 8.0m, Q1 2025 4.5m, Q2 2025 5.6m +1.2m +1,161,403 26.1%
37 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 268,000 $3.8m0.75% 0.75% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 268.0k
38 DOXIMITY INC CL A DOCS DOCS 60,000 $3.7m0.74% 0.74% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 122.5k, Q2 2025 60.0k -62.5k -62,500 -51.0%
39 XENON PHARMACEUTICALS INC COM XENE XENE 107,891 $3.4m0.68% 0.68% ReducedShares held: Q3 2024 818.0k, Q4 2024 474.0k, Q1 2025 229.0k, Q2 2025 107.9k -121.1k -121,109 -52.9%
40 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 33,800 $3.2m0.64% 0.64% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 33.8k
41 UNIQURE NV SHS QURE QURE 207,000 $2.9m0.58% 0.58% ReducedShares held: Q3 2024 673.6k, Q4 2024 222.0k, Q1 2025 336.2k, Q2 2025 207.0k -129.2k -129,200 -38.4%
42 APOGEE THERAPEUTICS INC COM COM 65,000 $2.8m0.57% 0.57% NewShares held: Q3 2024 154.0k, Q4 2024 0, Q1 2025 0, Q2 2025 65.0k
43 SOLENO THERAPEUTICS INC COM SLNO SLNO 32,000 $2.7m0.54% 0.54% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 32.0k, Q2 2025 32.0k
44 CARDINAL HEALTH INC COM CAH CAH 15,000 $2.5m0.51% 0.51% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 15.0k
45 ARS PHARMACEUTICALS INC COM SPRY SPRY 140,000 $2.4m0.49% 0.49% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 140.0k
46 KEZAR LIFE SCIENCES INC COM NEW KZR KZR 502,600 $2.3m0.46% 0.46% UnchangedShares held: Q3 2024 0, Q4 2024 502.6k, Q1 2025 502.6k, Q2 2025 502.6k
47 INTELLIA THERAPEUTICS INC COM NTLA NTLA 232,000 $2.2m0.44% 0.44% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 232.0k
48 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 39,000 $1.8m0.37% 0.37% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 39.0k
49 ARVINAS INC COM ARVN ARVN 243,162 $1.8m0.36% 0.36% ReducedShares held: Q3 2024 1.5m, Q4 2024 1.4m, Q1 2025 413.2k, Q2 2025 243.2k -170.0k -170,000 -41.1%
50 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 150,000 $1.4m0.28% 0.28% ReducedShares held: Q3 2024 2.5m, Q4 2024 1.5m, Q1 2025 925.0k, Q2 2025 150.0k -775.0k -775,000 -83.8%
51 SCYNEXIS INC COM NEW COM NEW 1,228,910 $829.3k0.17% 0.17% UnchangedShares held: Q3 2024 1.4m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.2m
52 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 134,566 $580.0k0.12% 0.12% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 134.6k, Q2 2025 134.6k
53 ALTIMMUNE INC COM NEW ALT ALT 105,000 $406.4k0.08% 0.08% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 105.0k
54 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 11,300 $226.7k0.05% 0.05% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 11.3k, Q2 2025 11.3k
55 REVIVA PHARMACEUTCLS HLDGS I COM COM 138,000 $52.6k0.01% 0.01% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 138.0k, Q2 2025 138.0k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
REGENERON PHARMACEUTICALS REGN REGN 25,400 $16.1m25.4k shares
GLAUKOS CORP GKOS GKOS 134,000 $13.2m134.0k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 80,000 $9.9m80.0k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 85,700 $9.5m85.7k shares
SPDR SER TR XBI XBI 94,000 $7.6m94.0k shares
CENTESSA PHARMACEUTICALS PLC 529,000 $7.6m529.0k shares
AVANTOR INC AVTR AVTR 453,000 $7.3m453.0k shares
IDEAYA BIOSCIENCES INC IDYA IDYA 445,000 $7.3m445.0k shares
JANUX THERAPEUTICS INC JANX JANX 258,000 $7.0m258.0k shares
BLUEPRINT MEDICINES CORP BPMC BPMC 68,500 $6.1m68.5k shares
UNITED THERAPEUTICS CORP DEL UTHR UTHR 16,800 $5.2m16.8k shares
BRUKER CORP BRKR BRKR 115,000 $4.8m115.0k shares
BIOHAVEN LTD BHVN BHVN 145,000 $3.5m145.0k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 169,000 $2.8m169.0k shares
ROYALTY PHARMA PLC RPRX RPRX 87,000 $2.7m87.0k shares
CAPRICOR THERAPEUTICS INC CAPR CAPR 239,000 $2.3m239.0k shares
LEXEO THERAPEUTICS INC LXEO LXEO 645,000 $2.2m645.0k shares
VERA THERAPEUTICS INC VERA VERA 91,000 $2.2m91.0k shares
REGENXBIO INC RGNX RGNX 260,000 $1.9m260.0k shares
IONIS PHARMACEUTICALS INC IONS IONS 60,000 $1.8m60.0k shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 40,000 $1.8m40.0k shares
NEWAMSTERDAM PHARMA COMPANY NAMS NAMS 68,000 $1.4m68.0k shares
AGILON HEALTH INC 305,100 $1.3m305.1k shares
VAXCYTE INC PCVX PCVX 23,000 $868.5k23.0k shares
HYPERFINE INC HYPR HYPR 222,174 $159.1k222.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SYNDAX PHARMACEUTICALS INC SNDX · Call SNDXCall 340,000 $3.2m340.0k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
IMMUNIC INC 13G · filed 2026-04-17 9.9% +5.1 pts 13G 2026-04-17
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 CNTX 8.7%≈ $4.6m -1.2 pts 13G 2026-05-12
PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 CATX 5.3%≈ $20.6m +1.1 pts 13G 2026-03-10